Podocalyxin variants and risk of prostate cancer and tumor aggressiveness - Wikidata - awgldk - TriplyDB

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

http://www.wikidata.org/entity/Q28293538

about

Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells Inherited susceptibility for aggressive prostate cancer Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma Rab35 GTPase couples cell division with initiation of epithelial apico-basal polarity and lumen opening.The cell surface mucin podocalyxin regulates collective breast tumor budding.Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat.PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays A comparative study of two PODXL antibodies in 840 colorectal cancer patients.Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes.Podocalyxin is a marker of poor prognosis in colorectal cancer Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.Methylation of an intronic region regulates miR-199a in testicular tumor malignancy.Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.Podocalyxin as a Prognostic Marker in Gastric Cancer Erythropoietin modulation of podocalyxin and a proposed erythroblast niche.Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Enhanced Cross-Linking of Diazirine-Modified Sialylated Glycoproteins Enabled through Profiling of Sialidase Specificities.The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.Markers for detection of prostate cancer.Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma.Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.Role of podocalyxin in astrocytoma: Clinicopathological and in vitro evidence Results from a prostate cancer admixture mapping study in African-American men.Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population.

P2860

Q24306767-FBED7D5E-5E1B-4CB1-AD9D-F02A08DA03ED Q24548405-7B7E396E-656B-471B-9750-C676DB65EE07 Q24653465-D7360864-EFAA-4E05-A63F-5074B34E5142 Q27001297-9F912A70-B36C-474F-99B3-6ECAA533D758 Q27303569-179C2CEE-1CCE-46D8-854B-90BD11302C0B Q27321208-CC767D13-AA02-4768-AF17-A52D5A14C1FC Q27338644-F62B0A5A-F60C-4C98-9AFD-F7ECDF4FE05A Q27496689-7CAE880E-5DCE-4C3E-AD16-F7F3EC56E7D3 Q33560353-5F98D469-3083-443E-81D6-D47EE8EEF157 Q33600992-94B31994-116C-4706-A041-C787A31F6329 Q33718734-7D69996E-033A-42A3-959B-EC5E244F3540 Q33938468-D0667515-EE9A-4779-B6E2-184146CF4D84 Q34053437-3D97D569-FD07-4D90-90EF-0E508D6610ED Q34485223-C840D0F9-31FA-45FE-AC38-80338E7223C0 Q34524949-68D32C49-6EAE-4AEE-BBBB-C72CB56F3388 Q35022551-20024575-0847-4B77-BBBA-6541386ABBD8 Q35053495-3F3369ED-76DC-4132-B0C3-AA246CA18F5D Q35287580-1A9F6145-6E3A-40F1-AA8A-559DB00D27CC Q35656610-89C92AA1-1DC8-446B-8D81-F8C68C2116F2 Q35870705-38E6D53D-002A-467F-A243-063F56E0485A Q35900969-912B50D9-3207-4C9D-8E7E-CB8D10103108 Q36100579-085030AB-32BB-4ADA-A3B3-AFCD3EED6383 Q36514827-4A60D95F-678E-4C03-8819-517E4BD414DD Q36756141-ED1871E3-B6B9-4058-AA51-206EB1D073E2 Q36886612-3D97A337-DD68-4643-98FC-1E935A00073E Q36924797-672BB91C-F08A-4F2B-9CF2-59574678E26A Q37114865-52115F6A-2AAF-4DCC-8E2B-47B03818B23F Q37328403-3F3EFBD5-650B-4396-BC9E-9179FD0B8E4B Q37375238-EAE7EF53-0A2A-428D-A575-FF4B5B18ABC0 Q37735632-8DE7C3FA-CE6B-4D4D-9D64-6CFB41D9F706 Q38259585-C063E727-3FC5-469F-A463-C042BBE0F4B3 Q38709426-4C49F3FA-DCEC-4D52-8DF2-F318A58EE593 Q39081304-BE5F071D-A5B8-4A66-A402-9E841C4085CB Q39409441-4B7201A9-7322-4A4E-BDF3-9D1FCF761CD9 Q40311743-677419A0-C3C1-4C51-9762-13901E49CD7B Q41790462-25F73180-E0AF-4750-B201-D330E52C26DC Q42378593-2C06F0BB-3B96-4E21-903E-ADFBF6897DD4 Q46238878-0F08D5EF-EDAB-4787-BFFF-CBF02D656895 Q47694823-A587B414-6182-4B7B-A5FB-7C1F82F97C75 Q51804729-3675CF37-49DA-451C-A473-E962B0CEBAE1

P2860

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

http://www.wikidata.org/entity/Q28293538

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@ast

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@en

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@nl

type

label

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@ast

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@en

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@nl

prefLabel

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@ast

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@en

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@nl

P1433

Q28293538-1A499952-4E91-4437-A311-9289E458FE5C

P1476

Q28293538-F997B785-57A2-4444-8570-8A5AC78D7C64

P2093

Q28293538-0575A377-0EDA-4AC5-B67E-75D84CD725FD

Q28293538-07785FC2-FBA5-45D1-9909-1DA49A9AF68D

Q28293538-250C6C4A-3BF0-4CFA-A274-8886CE29D045

Q28293538-4E2AB42C-BDB1-4124-BC58-CCD4AAD7C4CA

Q28293538-687030F1-2922-4772-BA5D-08A919B4A3A8

Q28293538-86DB6FEF-857F-4427-BED7-06DAEF6ED722

Q28293538-C84E5FBC-A322-4C14-AE4A-7D6E4270DC2E

Q28293538-E17EDE77-52F6-4123-8611-03A34962F9D1

Q28293538-EC861492-414C-4CFA-A59A-3916F1373828

Q28293538-F90A0016-B494-4ED4-A9C6-6DD0B75FD5DF

P2860

Q28293538-46D2092B-D54A-49B0-9F82-2FDE10B313DF

Q28293538-6F613E80-180F-498B-8FE4-12ED9867C485

Q28293538-7AB3A697-9EF6-4DCD-923F-CC2B5CC52536

Q28293538-7ABCD52F-2C8F-4CFB-B67B-672BCB7BAEFC

Q28293538-AF09ECC1-5E56-4BD5-92F7-DEF88D43F3C2

Q28293538-B1ABE932-1565-4F29-9107-287CD8C0F1A2

Q28293538-D299698F-65B0-424E-AE5A-6BBE4B2E22BA

Q28293538-DAAAED30-EF63-4E8C-A43D-8FD0D5C8631F

Q28293538-E13709C9-5818-4A98-9126-40E10D139206

P304

Q28293538-3F62468B-B475-45B5-90ED-0CC428CA1469

P31

Q28293538-FCB5A7C5-21FD-4A6E-ABD3-AAC1B7EBFF61

P3181

Q28293538-2669F091-D908-41B2-A8E4-3774B16153EC

P356

Q28293538-3B1CD22E-A53A-4518-845F-9ED22299FCAA

P407

Q28293538-E476AEE6-7A9A-4ABE-9FD1-4D0BD1C757E3

P433

Q28293538-8313F349-0D82-4576-8D68-C94B2309B7F3

P478

Q28293538-B883FCDD-0323-4BD8-93AE-9516ED2CE923

P50

Q28293538-3A7A8CC3-A7EB-40B7-A2A9-A3CE73ACA415

P577

Q28293538-D20F7955-455D-4BA2-AC06-DDB7F6FF4D89

P5875

Q28293538-6FA499E5-CEE3-4E31-B127-834D208F28F4

P698

Q28293538-7B1C2F89-50B3-4AF4-B7D7-8E03C8FE45E4

P3181

P356

P1433

Human Molecular Genetics

P1476

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

@en

P2093

Anthony P Curran

http://www.w3.org/2001/XMLSchema#string

Eric A Klein

http://www.w3.org/2001/XMLSchema#string

John S Witte

http://www.w3.org/2001/XMLSchema#string

Lisa M Krumroy

http://www.w3.org/2001/XMLSchema#string

Michelle R McGreevy

http://www.w3.org/2001/XMLSchema#string

Mine S Cicek

http://www.w3.org/2001/XMLSchema#string

Phillippa J Neville

http://www.w3.org/2001/XMLSchema#string

Sarah J Plummer

http://www.w3.org/2001/XMLSchema#string

William J Catalona

http://www.w3.org/2001/XMLSchema#string

Xin Liu

http://www.w3.org/2001/XMLSchema#string

P2860

WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis

Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34

Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway

Somatic acquisition and signaling of TGFBR1*6A in cancer.

Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.

Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.

Expression of ezrin in prostatic intraepithelial neoplasia.

P304

735-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1764335

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/HMG/DDI487

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7339979

http://www.w3.org/2001/XMLSchema#string

P698

16434482

http://www.w3.org/2001/XMLSchema#string